WO2016181187A1 - Composición para el tratamiento de parasitosis por gregarinas en camarones - Google Patents
Composición para el tratamiento de parasitosis por gregarinas en camarones Download PDFInfo
- Publication number
- WO2016181187A1 WO2016181187A1 PCT/IB2015/053459 IB2015053459W WO2016181187A1 WO 2016181187 A1 WO2016181187 A1 WO 2016181187A1 IB 2015053459 W IB2015053459 W IB 2015053459W WO 2016181187 A1 WO2016181187 A1 WO 2016181187A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- active compound
- composition
- toltrazuril
- trimethoprim
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
Definitions
- the present invention is related to the treatment of diseases in aquatic animals, preferably those obtained through aquaculture. More particularly, the present invention relates to a composition for the treatment of gregarin parasitosis in wild or cultivated shrimp.
- Gregarins are protozoan parasites of invertebrates, especially in arthropods, annelids and mollusks.
- Gregarin parasitosis especially those of the Nematopsis and Cephalolobus genera, is a problem for shrimp producers, since they are present almost all over the world.
- Some farms use lime to control gregarins in shrimp farming, obtaining some positive results.
- frequent use of lime in shrimp feed can cause irritation or injury to the intestines of shrimp that consume it, which also affects their growth and production.
- a composition for the treatment of gregarin parasitosis in shrimp has been developed that, in addition to safely and effectively controlling gregarin parasitosis in shrimp, allows for a treatment that is effective at all stages of development of gregarins, which is not toxic to animals or humans, and that is easy to apply or administer in shrimp crops, so that productive parameters are improved.
- a composition for the treatment against gregarin parasitosis in shrimp has been invented, which comprises at least one active compound that is selected from lasolacid, salinomycin, narasin, maturemicin, semduramycin, 3-nitro phenyl arsonic acid, arsanilic acid , amprolium, decoquinate, diclazuril, ethopabate, halofuginone, lasalocid, maturemicin, methylchlorpindole, monensin, narasin, nicarbacin, robenidine, salinomycin sodium, sodium semduramycin, toltrazuril (1-methyl-3- [3-methyl-4- [4- (methyl-4- trifluoromethyl) thio) phenoxyl] phenyl] -1,3,5-triazine (1 H, 3H, 5H) -2,4,6-trione), or trimethoprim (5 - [(3,4,5-trimethoxyphenyl) methyl
- composition comprising at least one active compound selected from Lasolacid, Salinomycin, Narasin, Maduramycin, Semduramycin, 3-Nitro Phenyl Arsonic Acid, Arsanilic Acid, Amprolium, Decoquinate, Diclazuril, Etopabate, Halofuginone, Lasalocid, Madinamycin, Methyl Chlorpindole, Monensin, Narasin, Nicarbodin, Sodium, Sodium, Sodium, Sodium, Sodium, Sodium, Sodium toltrazuril (1-methyl-3- [3-methyl-4- [4- (trifluoromethyl) thio) phenoxy] phenyl] -1, 3,5-triazine (1 H, 3H, 5H) -2,4,6- trione), or trimethoprim (5- [(3,4,5-trimethoxy
- the term “shrimp” is used to refer to all those decapod crustaceans of the Caridea, wild or cultivated infraorder, including white shrimp ⁇ Litopenaeus vannamei).
- greyina refers to those protozoa of the Apicomplexa phylum belonging to the subclass Gregarinasina or Gregarinia, including the genera Nematopsis and Cephalolobus.
- the active compound is selected from toltrazuril or trimethoprim or a combination thereof.
- the composition of the present invention comprises a combination of the toltrazuril and trimethoprim compounds. It was found that the best weight ratio between these particular active compounds is in the range of 1: 1 to 1: 5 (toltrazuril: trimethoprim).
- shrimp have from 1 day to 32 weeks of sowing.
- the composition of the present invention is in combination with a pharmaceutically acceptable excipient forming a pharmaceutical composition.
- the pharmaceutically acceptable excipient is selected from organic and inorganic liquids or solids, among which are starch, lactose, glucose, sucrose, dextrin, alpha cyclodextrins, beta cyclodextrins, cyclodextrin range, cellulose, paraffin, water, alcohol, polyethylene glycol, propylene glycol , trietanoamine, gum arabic, grenetina, carbopol, poloxamers, chitosan, dimethyl sulfoxide, alone or combinations thereof.
- the pharmaceutical composition is in the form of a suspension or solution. Moreover, it is preferred that the pharmaceutical composition comprises 20 to 150 mg of active compound per mL of suspension or solution.
- the pharmaceutical composition comprises 20 to 30 mg of toltrazuril per mL of suspension or solution, and / or 20 to 150 mg of trimethoprim for every mL of suspension or solution.
- a shrimp feed composition for the treatment and control of gregarin parasitosis comprising: a. an effective amount of at least one active compound selected from lasolacid, salinomycin, narasin, maturemicin, semduramycin, 3-nitro phenyl arsonic acid, arsanilic acid, amprolium, decoquinate, diclazuril, ethopabate, halofuginone, lasalocid, maturemycin, methylchlorpindole, monensin narasin, nicarbacin, robenidine, sodium salinomycin, sodium semduramycin, toltrazuril (1-methyl-3- [3-methyl-4- [4- (trifluoromethyl) thio) phenoxy] phenyl] -1, 3,5-triazine (1 H , 3H, 5H) -2,4,6-trione), or trimethoprim (5 - [(3,4,5-trimethoxyphen
- the source of organic matter for the fattening of aquatic species of the food composition comprises natural foods, which are those naturally present in the ponds; and / or, complementary foods, which are foods that are regularly supplied to aquaculture species in cultivation.
- Natural foods can be selected from detritus, bacteria, plankton, worms, insects, snails, aquatic plants and fish, among others.
- Complementary foods can be selected from land plants, food waste or products derived from agriculture.
- the source of organic matter for the fattening of aquatic species may comprise supplements, which are mixtures of carefully selected ingredients to provide all the necessary nutritive elements for the aquatic species to grow properly.
- the source of organic matter for the fattening of aquatic species may comprise one or more of the following: fishmeal, wheat and wheat by-products, wheat flour, meat meal, feather and viscera flour, cornmeal, sorghum flour, sorghum, wheat, soy, gluten, cooked corn, fish oil, soy, vitamins, minerals, choline chloride, ascorbic acid, beer yeast, methionine, or folic acid.
- the food composition of the present invention is administered to a group of shrimp infested with gregarins, and / or susceptible to infestation with gregarins, and / or with symptoms caused by gregarin parasitosis.
- the food composition comprises 400 to 10,000 parts per million (ppm) of the active compound with respect to the total food composition.
- the food composition comprises 400 to 2000 parts per million (ppm) of toltrazuril as active compound and / or 400 to 10,000 ppm of trimethoprim as active compound with respect to the total food composition.
- the feed composition comprises 500 to 1000 parts per million (ppm) of toltrazuril as active compound and / or 1000 to 2000 ppm of trimethoprim as active compound with respect to the total food composition.
- the present invention also provides the use of the pharmaceutical and / or food composition for the treatment and / or control of parasitosis by gregarins in shrimp.
- the way of using the food composition comprises administering to a group of shrimp the food composition as part of their normal diet, so it is easy to administer in shrimp cultures.
- the food composition is administered daily for a period of 1 to 5 days, more preferably for a period of 1 to 3 days.
- the test was carried out in a recirculation culture system within the Wet Laboratory of Aquaculture Nutrition of the Kino Experimental Unit (UEK), Kino Bay, Sonora, with 100 circular tanks of 30 cm in diameter, 19 L capacity and area surface area of 0.07 m 2 .
- the water recirculated from a main collecting tank of 1,700 L capacity, which pumped the water through components such as biological and mechanical filtration, in addition to an ultraviolet light chamber for its disinfection, to finally be sent to the culture tanks. Water temperature was controlled with automatic heaters with integrated thermostat.
- aeration was provided to each culture tank with 3/16 "diameter plastic hoses and a diffuser stone, injecting it with a 1 HP blower.
- juvenile shrimps were obtained from a commercial farm infested with gregarins, with an average individual weight of 10.6 g.
- the organisms were placed in the experimental tanks, at the rate of 4 individuals per tank.
- Experimental treatments consisted of a preferred embodiment of the food compositions, particularly a combination of the active toltrazuril and trimethoprim compounds of the present invention, designated for the purposes of the T1 and T2 assay, supplied through the balanced feed, and a third treatment.
- T3 or control treatment which consisted solely of balanced feed.
- the treatments T1, T2 and T3 were assigned to a total of 38, 38 and 24 tanks, respectively, distributed in the culture system.
- T1 and T2 a solution of the compounds toltrazuril and trimethoprim was used, with an amount of 25 mg / mL of toltrazuril, 50 mg / mL of trimethoprim and 1 mL of excipient c.b.p.
- the above solution was diluted in a solution of water and grenetina (20 g grenetina / L of water) in a ratio of 1: 4 (ie, 1 mL of solution of toltrazuril and trimethoprim compounds plus 4 mL of water and grenetine solution ) for the preparation of the T1 treatment, and in a ratio of 1: 1 .5 (ie, 1 mL of solution of the toltrazuril and trimethoprim compounds plus 1 .5mL of water and grenetine solution) for the preparation of the T2 treatment.
- Grenetine was used in order that the toltrazuril and trimethoprim compounds contained in the solution adhere to the food granules.
- the T1 treatment comprises a food composition with a toltrazuril concentration of 500 ppm, while the trimethoprim concentration is 1000 ppm.
- the T2 treatment comprises a food composition with a toltrazuril concentration of 1000 ppm, while the trimethoprim concentration is 2000 ppm.
- Shrimp were fed with treatments T1, T2 and T3 for three days at a feeding rate of 2% of the shrimp group weights in each tank. This rate was previously identified as an adequate rate because the shrimp from all the tanks consumed it in its entirety.
- composition of the toltrazuril and trimethoprim compounds according to the present invention provides a safe and effective treatment against gregarin parasitosis in shrimp.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2017014439A MX2017014439A (es) | 2015-05-11 | 2015-05-11 | Composicion para el tratamiento de parasitosis por gregarinas en camarones. |
PCT/IB2015/053459 WO2016181187A1 (es) | 2015-05-11 | 2015-05-11 | Composición para el tratamiento de parasitosis por gregarinas en camarones |
BR112017024363-6A BR112017024363B1 (pt) | 2015-05-11 | 2015-05-11 | Composições alimentícia compreendendo toltrazuril e trimetoprima e uso de uma combinação de toltrazuril e trimetoprima para o tratamento de parasitose por gregarinas em camarões |
ECIEPI201781673A ECSP17081673A (es) | 2015-05-11 | 2017-12-11 | Composición para el tratamiento de parasitosis por gregarinas en camarones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2015/053459 WO2016181187A1 (es) | 2015-05-11 | 2015-05-11 | Composición para el tratamiento de parasitosis por gregarinas en camarones |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016181187A1 true WO2016181187A1 (es) | 2016-11-17 |
Family
ID=57249567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/053459 WO2016181187A1 (es) | 2015-05-11 | 2015-05-11 | Composición para el tratamiento de parasitosis por gregarinas en camarones |
Country Status (4)
Country | Link |
---|---|
BR (1) | BR112017024363B1 (es) |
EC (1) | ECSP17081673A (es) |
MX (1) | MX2017014439A (es) |
WO (1) | WO2016181187A1 (es) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010013129A1 (es) * | 2008-07-31 | 2010-02-04 | Laboratorio Avi-Mex, S.A. De C.V. | Combinación coccidicida para uso veterinario |
WO2011013464A1 (ja) * | 2009-07-28 | 2011-02-03 | 日東紡績株式会社 | デヒドロゲナーゼまたは対応する基質の測定方法および測定用キット |
-
2015
- 2015-05-11 WO PCT/IB2015/053459 patent/WO2016181187A1/es active Application Filing
- 2015-05-11 BR BR112017024363-6A patent/BR112017024363B1/pt active IP Right Grant
- 2015-05-11 MX MX2017014439A patent/MX2017014439A/es unknown
-
2017
- 2017-12-11 EC ECIEPI201781673A patent/ECSP17081673A/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010013129A1 (es) * | 2008-07-31 | 2010-02-04 | Laboratorio Avi-Mex, S.A. De C.V. | Combinación coccidicida para uso veterinario |
WO2011013464A1 (ja) * | 2009-07-28 | 2011-02-03 | 日東紡績株式会社 | デヒドロゲナーゼまたは対応する基質の測定方法および測定用キット |
Non-Patent Citations (2)
Title |
---|
E. J. FAJER-AVILA ET AL.: "Effectiveness of oral Elancoban? and Avimix-ST? against Nematopsis (Apicomplexa: Porosporidae) gametocyts infecting the shrimp Litopenaeus vannamei", AQUACULTURE, vol. 244, 2005, pages 11 - 18, XP055330878 * |
K. MOLNAR ET AL.: "Efficacy of some anticoccidial drugs for the treating coccidial enteritis of the common carp caused by Goussia Carpelli (Apicomplexa: Eimeriidae", ACTA VETERINARIA HUNGARICA, vol. 55, no. 1, 2007, pages 67 - 76, XP055330879 * |
Also Published As
Publication number | Publication date |
---|---|
MX2017014439A (es) | 2018-03-02 |
BR112017024363B1 (pt) | 2023-03-14 |
BR112017024363A2 (pt) | 2018-07-31 |
ECSP17081673A (es) | 2018-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vidal et al. | Cephalopod culture: current status of main biological models and research priorities | |
Pandian et al. | Energetics of feeding and digestion | |
NL192087C (nl) | Bestrijding van coccidiosis. | |
CN1454058A (zh) | 生物活性食品复合物,制备生物活性食品复合产品的方法和用于控制疾病的方法 | |
DK2371226T3 (en) | BILD SALT ADJUSTMENT TO ANIMALS TO IMPROVE THE FAT USE EFFECTIVENESS OF ANIMAL ORGANIZATIONS | |
US20120071557A1 (en) | Animal feed compositions of abscisic acid | |
WO2009063044A1 (en) | Treatment of parasite diseases using vitamin k3 | |
CN110178973A (zh) | 一种防治凡纳滨对虾肝肠胞虫的药饵添加剂 | |
CN101010075B (zh) | 提高有壳水生动物的健康、免疫性和生长的物质和方法 | |
CN1659977A (zh) | 鳝鱼用饲料 | |
CN106035146A (zh) | 青鱼、鲫鱼池塘套养技术 | |
CN105532519A (zh) | 高营养价值的黄颡鱼养殖方法 | |
KR20210017464A (ko) | 노니를 이용한 반려동물용 항염증 영양보조제 및 이의 제조방법 | |
CN105706971A (zh) | 澳洲龙纹斑鱼苗的培养方法 | |
WO2016063105A1 (es) | Composición para el tratamiento de ectoparasitosis y la promoción del crecimiento en acuicultura | |
KR101935821B1 (ko) | 동애등에 및 알로에를 포함하는 관상어 사료와 그 제조방법 | |
Roca et al. | Improving larval culture and rearing techniques on common snook (Centropomus undecimalis) | |
WO2016181187A1 (es) | Composición para el tratamiento de parasitosis por gregarinas en camarones | |
McTurk et al. | Hand‐rearing and rehabilitation of orphaned wild giant otters, Pteronura brasiliensis, on the Rupununi river, Guyana, South America | |
CN107318712A (zh) | 一种红白锦鲤的养殖方法 | |
Khalil et al. | Impact of sodium lactate as a growth promoter on the hepatopancreas of the freshwater prawn Macrobrachium rosenbergii (de Man, 1879) | |
JP2000281568A (ja) | 寄生虫症予防治療剤 | |
WO2010013129A1 (es) | Combinación coccidicida para uso veterinario | |
JPH07213234A (ja) | 養殖魚類に対する寄生虫症予防剤または予防方法 | |
JP2001122717A (ja) | 魚類の抗寄生虫抗微生物剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15891739 Country of ref document: EP Kind code of ref document: A1 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 002396-2017 Country of ref document: PE |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2017/014439 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112017024363 Country of ref document: BR |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15891739 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 112017024363 Country of ref document: BR Kind code of ref document: A2 Effective date: 20171113 |